Companies ranging from smaller, high-growth biotechs to large pharma multinationals engaged in lively talent and rewards discussions during Willis Towers Watson’s eleventh annual biopharma and health sciences industry roundtable for HR on May 17. The roundtable will be repeated in London on June 28.
Richard Belfield, Hemant Patel, Matthew Mullery, and Aman Malhotra
This year, Willis Towers Watson’s 2018 Canadian proxy webcast will offer the latest insights into current compensation trends and the shifting governance landscape in the 2018 proxy season.
If we were going to pick one principle, one concept, one word that best captures our job as executive compensation professionals, it would be alignment. The primary objective of all executive compensation programs should be to align the interests of management and owners. It should also motivate and reward excellent performance that advances the owners’ goals and objectives.
Despite alarmist headlines over the course of 2017 declaring a “retail apocalypse,” the industry produced a remarkable 43% total shareholder return (TSR) in fiscal 2018 and improved in other key growth measures. While we expect environmental challenges to persist in the retail industry, improved online sales growth coupled with the overall macroeconomic growth are causes for optimism in fiscal 2019.
Kate King and Chris Marques
You must be logged in to access this feature.